Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MannKind
AddedFeb 19, 2024
UpdatedJul 4, 2026
MannKind

MannKind

Public

MannKind Corp: A Connecticut-based biopharmaceutical firm specializing in diabetes and pulmonary treatments.

HQ
Danbury, CT, US
Founded
1991
Overview
Compare
Employees
Website

MannKind Corporation, founded in February 1991 and based in Danbury, Connecticut, is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutic products. The company's core mission is to improve the lives of people living with endocrine and orphan lung diseases, particularly focusing on diabetes and pulmonary arterial hypertension. MannKind leverages cutting-edge technology and a solutions-based approach to deliver effective treatments and devices that enhance patient outcomes.

Notable figures associated with MannKind include its founder, Alfred E. Mann, a renowned entrepreneur in the medical device industry. The company has achieved significant milestones, including the development and commercialization of Afrezza, an inhalable insulin product for diabetes management. MannKind's impact is evident in its commitment to advancing medical science and improving the quality of life for patients with chronic conditions. The company's innovative approach and dedication to patient care have positioned it as a key player in the biopharmaceutical industry.

MannKind - Similar Companies

Insulet logo

Insulet

insulet.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Tandem Diabetes Care logo

Tandem Diabetes Care

tandemdiabetes.com

Novo Nordisk logo

Novo Nordisk

novonordisk.com

Sensulin logo

Sensulin

sensulin.com

Ascensia Diabetes Care logo

Ascensia Diabetes Care

ascensia.com

Pulmatrix logo

Pulmatrix

pulmatrix.com

United Therapeutics logo

United Therapeutics

Insmed logo

Insmed

insmed.com

Exsulin logo

Exsulin

Thermalin logo

Thermalin

Lung Biotechnology logo

Lung Biotechnology

unither.com

Beta Bionics logo

Beta Bionics

Dexcom logo

Dexcom

dexcom.com

Vivus logo

Vivus

vivus.com

MannKind - Quick Facts

Who are MannKind's competitors?

Companies similar to MannKind include Insulet, Manhattan Pharmaceuticals, Tandem Diabetes Care and Novo Nordisk.

When was MannKind founded?

MannKind was founded in 1991.

Where is MannKind's headquarters located?

MannKind's headquarters is located in Danbury, CT, US.

How many employees does MannKind have?

MannKind has 233 employees as of Feb 6, 2024.

MannKind - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0000899460
  • ticker: MNKD
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
  • 7210Research and experimental development on natural sciences and engineering
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified